PST2238 (Rostafuroxin) As An Antiviral Drug Against Respiratory Syncytial Virus (RSV) Read more about PST2238 (Rostafuroxin) As An Antiviral Drug Against Respiratory Syncytial Virus (RSV) US Application 17/725,331Filed on 2022-04-20
DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS Read more about DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS US Patent 11,746,335Filed on 2022-04-19
Zika Viral Antigen Constructs Read more about Zika Viral Antigen Constructs European Patent21216477.6Filed on 2021-12-21
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Hong Kong42021042265.5Filed on 2018-10-04
SIRPalpha Expression On T Cells Is A Biomarker For Functional T Cells During Exhaustion Read more about SIRPalpha Expression On T Cells Is A Biomarker For Functional T Cells During Exhaustion US Application 17/425,224Filed on 2021-07-22
SIRPalpha Expression On T Cells Is A Biomarker For Functional T Cells During Exhaustion Read more about SIRPalpha Expression On T Cells Is A Biomarker For Functional T Cells During Exhaustion Patent Cooperation TreatyPCT/US2020/015905Filed on 2020-01-30
COMPOSITIONS OF MATTER COMPRISING STABILIZED CORONAVIRUS ANTIGENS AND THEIR USE Read more about COMPOSITIONS OF MATTER COMPRISING STABILIZED CORONAVIRUS ANTIGENS AND THEIR USE Patent Cooperation TreatyPCT/US2022/070744Filed on 2022-02-18
CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN Read more about CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN US Application 17/332,901Filed on 2021-05-27
RECOMBINANT VIRUS WITH DIMINISHED LATENCY AND METHODS OF USING SAME Read more about RECOMBINANT VIRUS WITH DIMINISHED LATENCY AND METHODS OF USING SAME US Application 17/692,540Filed on 2022-03-11
TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION Read more about TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR TREATMENT OF HIV INFECTION South Africa2021/08577Filed on 2020-04-08